PT  - JOURNAL ARTICLE
AU  - Cunningham, Muriel
ED  - Cooper, Christopher J.
TI  - No Benefit to Renal Artery Stenting Seen in CORAL Trial
DP  - 2013  01
TA  - MD Conference Express
PG  - 22--24
VI  - 13
IP  - 20
4099  - http://mdc.sagepub.com/content/13/20/22.2.short
4100  - http://mdc.sagepub.com/content/13/20/22.2.full
AB  - Atherosclerotic renal artery stenosis (RAS) becomes more prevalent with age and is often incidentally diagnosed, but existing data is unclear as to whether revascularization of RAS prevents major adverse cardiovascular events. The objective of the Cardiovascular Outcomes in Renal Atherosclerotic Lesions study [CORAL] was to determine whether renal artery stenting, in combination with optimal medical therapy, could reduce the incidence of major clinical events in patients with both atherosclerotic RAS and a potentially related clinical syndrome—either systolic hypertension or chronic kidney disease.